Animal protein hydrolysate composite dressing based on enzyme and deep-eutectic solvent

Through the combination of animal proteolytic hydrolysate based on enzymes and eutectic solvents, combining calcium lactate and heme, the existing skin care dressings have limited functions and complex preparation problems, and a multifunctional dressing with comprehensive functions and stable properties has been achieved. , improve transdermal absorption efficiency and develop high-value applications of waste resources.

CN119055538APending Publication Date: 2024-12-03SICHUAN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310629610.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-31
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing skin care dressings have limited functions and are difficult to effectively repair damaged skin barriers. The preparation process is complex and costly, and there is a problem of membrane matrix being volatile for hydrosclerosis.

Method used

Using animal protein hydrolysate composite dressing based on enzymes and eutectic solvents, using waste, enzymes, eutectic solvents, natural polysaccharides and other materials for the minced meat food processing industry, to prepare composite membranes by blending and compounding, combining calcium lactate as Crosslinking agents and heme are added components to achieve versatility and stability.

Benefits of technology

It has achieved a multifunctional skin care dressing with comprehensive functions and stable properties, improved transdermal absorption efficiency, expanded the type and composition of dressings, solved the problem of poor basic performance of membrane materials, and achieved high-value development of waste animal resources.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004257984910000011
    Figure HDA0004257984910000011
  • Figure HDA0004257984910000012
    Figure HDA0004257984910000012
  • Figure HDA0004257984910000013
    Figure HDA0004257984910000013
Patent Text Reader

Abstract

The invention discloses a composite dressing based on an enzyme and deep-eutectic solvent hydrolyzed animal protein product. The animal protein raw material comes from wastes of the food processing industry, and an enzyme and a deep eutectic solvent are taken as cores to form a catalytic system. After hydrolysis is completed, calcium lactate, a deep-eutectic solvent and hydrolysate are sequentially added into a pectin and carrageenan mixture aqueous solution serving as a membrane casting solution matrix, stirring is conducted, finally, heme from industrial waste is added, further even mixing is conducted, and the calcium lactate-carrageenan composite membrane is prepared through the processes of concentration, defoaming, flow casting, drying and the like. Wherein the protein hydrolysate is a main functional substance, the heme is an additive component, the calcium lactate is a cross-linking agent, and the eutectic solvent simultaneously plays multiple roles of a solvent, a dispersing agent, a cocatalyst, a plasticizer, a penetration enhancer, a bacteriostatic agent and the like. The obtained composite film is good in character and rich in function, the related preparation process is simple, the cost is low, the film forming property is high, functional substances are convenient to add, and high-value development and utilization of industrial waste resources are achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of health care and beauty / nursing dressings, and in particular relates to a composite component dressing film derived from animal protein hydrolysate and having multiple functions and a preparation method thereof. Background Art

[0002] The skin is the largest organ in the human body, and its main functions are to prevent bacteria and viruses from invading the body, regulate body temperature, and excrete sweat. However, if its barrier function is damaged due to physical, chemical, pathogenic microorganisms, abnormal immune responses, and other factors, it will have a significant impact on the patient's life. How to effectively repair it has become one of the long-standing problems in clinical medicine. Skin care dressings can play a physical barrier role by forming a protective layer on the surface of the wound. In addition, by adding effective ingredients, they can also relieve uncomfortable symptoms such as skin chapped, frostbite, ulceration, itching, redness, swelling, eczema, acne, dryness, etc.; it can not only repair damaged skin barriers and accelerate wound healing, but also has great application potential in the field of skin health care and beauty; but the currently available large-area care dressings with more comprehensive functions are very limited.

[0003] Protein is a commonly used functional component in beauty care products, and related skin care products and preparations have been well applied in daily care and clinical medicine. Animal tissue raw materials are rich in various proteins that are beneficial to skin health (such as collagen, keratin, etc.). At the same time, related industries will produce a large amount of waste containing animal protein during processing, which urgently needs to be effectively developed and utilized. However, such ingredients are often too large in molecular weight and poor in water solubility, so they cannot be effectively absorbed and utilized by the body. Injectable collagen has improved the above shortcomings to a certain extent. It can directly enter the inside of the skin, play a role in repairing tissues and maintaining skin moisture, and can also improve skin elasticity to a certain extent. However, its use requires professional operation, and there is a certain risk of rejection, which may cause allergies and other problems. How to fully solve the safety and effectiveness of this type of active ingredient in the direction of care application is the focus of current research and development.

[0004] In recent years, skin care and beauty products derived from various protein hydrolysates have attracted widespread attention. They can be absorbed by the body more quickly and are more likely to promote surface repair and regeneration of the dermis, thereby accelerating the renewal of the keratin barrier. Protein hydrolysis methods mainly include chemical methods and enzymatic methods. The degree of hydrolysis in the former is often difficult to control, and acid-base catalysts that are not friendly to the environment and personnel are often used; while the latter is relatively mild, with a moderate degree of hydrolysis, retaining more active peptide components. Related enzymatic hydrolysis reactions often occur in water environments, but many substrates have poor solubility in water, and side reactions associated with hydrolysis often occur. With the deepening of basic research, enzymes have been found to be able to maintain their original catalytic activity in some organic solvents. Compared with catalytic reactions in water, some enzymes even show higher catalytic activity (Journal of Physical Chemistry B, 2017, 121 (29): 7027-7041.). However, with the development and popularization of green chemistry, considering the certain hazards of these organic solvents and their potential impacts on the environment and operators, there is an urgent need to find new green enzyme-catalyzed reaction solvents to replace them.

[0005] Deep Eutectic Solvent (DES) is a new type of multi-purpose green solvent composed of a hydrogen bond donor (HBD) and a hydrogen bond acceptor (HBA) in a certain molar ratio. It exists in liquid form at room temperature. Its application in the fields of biomedicine and functional materials is currently in its infancy. Due to its unique physical and chemical properties, it has been found to be able to dissolve a variety of poorly soluble macromolecules represented by proteins. In addition, it has good biocompatibility, its own functionality (antibacterial, moisturizing, exfoliation, etc.) and the characteristics of promoting transmission and tissue penetration, making it have great potential in the application direction of topical transdermal preparations. At the same time, existing studies have also proved the feasibility of enzyme catalytic reactions in DES. It has participated in the catalytic reaction process of lipase, catalase, lactate dehydrogenase, etc. as a solvent or co-catalyst (International journal of biological macromolecules, 2022, 217: 255-269.), with obvious effects. Related research is in its infancy, and there is an urgent need to explore the hydrolysis properties of enzymes (such as proteases) with poor stability in DES and their application in the field of nursing dressings.

[0006] Pectin and carrageenan are natural polymers mainly derived from plants. They are widely available, inexpensive, have a three-dimensional network structure that is easy to form, have good biocompatibility with the human body, and can also stabilize proteins, making them good film-forming materials. However, these polysaccharides have low strength and high brittleness after being dissolved in water. Once swollen, their strength and elastic modulus will decrease rapidly, making them unsuitable for use as membrane matrices alone. This deficiency greatly limits their application. The introduction of animal protein, low eutectic solvents and calcium lactate can often significantly improve their flexibility and strength. At the same time, these main components have good compatibility and stability with the natural polysaccharide system, and have the potential to be blended and compounded as composite materials.

[0007] In addition to protein waste from edible parts of animals, the processing of minced meat also produces congested tissue that is also in urgent need of utilization, which is rich in heme. It is an iron porphyrin compound and is a cofactor of hemoglobin, myoglobin, cytochrome, peroxidase, catalase, etc. When used as a medicine and health product, it can play an important biological function such as oxygen carrying, oxygen storage, promoting redox, and electron transfer; especially in skin care, it has the effects of beautifying and nourishing the skin, improving anemia, delaying aging, and preventing pigmentation (Pharmaceutical Industry, 1985 (08): 37-40). Therefore, using heme as an addable active ingredient is conducive to the development of more new medical or personal care materials, which can provide more options for clinical treatment and daily health care and beauty.

[0008] At present, the repair skin dressings used in daily care and clinical treatment have the problems of limited types and incomplete functions. At the same time, there are major problems such as complex formulas and processes, high preparation costs, special equipment required, and easy dehydration and hardening of the membrane matrix. The present invention provides a multifunctional composite skin care dressing mainly prepared from waste from the minced meat food processing industry, enzymes, low eutectic solvents, and natural polysaccharides. It has a novel formula, simple preparation, environmentally friendly process, comprehensive functions, and is easy to mass produce. At the same time, it solves the problem of poor basic performance of membrane materials and improves transdermal absorption efficiency; it not only expands the types and compositions of existing dressings, but also realizes the high-value development and multiple utilization of discarded animal resources, providing new ideas for further development of new care materials. Summary of the invention

[0009] The purpose of the present invention is to provide a composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent and a preparation method thereof, wherein the protein hydrolysate is the main functional substance, heme is an addable component, pectin and carrageenan are the membrane matrix, calcium lactate is a cross-linking agent, and the low eutectic solvent plays multiple roles such as dispersant, catalyst promoter, plasticizer, penetration promoter and antibacterial agent at the same time; in the film making process, pectin and carrageenan are used in a blending manner to compound and gel the components such as protein hydrolysate in the form of a transparent film; the preparation process involved is simple, the composite film has comprehensive functions and stable properties, and no special equipment is required during preparation, which has good development and application prospects. In the preparation link, each component shows obvious compatibility and combination advantages, and transdermal absorption components can be easily added to play a synergistic nursing role. The composite film has a smooth appearance and good uniformity; it is also easy to cut and easy to achieve large-scale preparation. The finished dressing shows the expected multiple properties, and also reflects the characteristics of being a drug release carrier.

[0010] Technical solution: In order to achieve the above purpose, a preparation method of a composite dressing based on animal protein hydrolysate of enzyme and low eutectic solvent was established:

[0011] A composite dressing based on animal protein hydrolysate of enzyme and low eutectic solvent, characterized in that the animal protein raw materials used come from defatted waste residues in the minced meat processing process of the food industry, including pork, beef, chicken or a mixture thereof, wherein the main waste is pork.

[0012] The composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent as claimed in claim 1 is characterized in that the enzyme used includes trypsin, α-chymotrypsin, papain or flavor protease.

[0013] The composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent as described in claim 1 is characterized in that the low eutectic solvent used includes choline chloride-urea (1:2), choline chloride-ethylene glycol (1:2), choline chloride-glycerol (1:2) or betaine-glycerol (1:2).

[0014] The composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent as described in claim 1 is characterized in that the hydrolysis system consists of animal protein raw material, enzyme, low eutectic solvent and 0.02M PBS buffer, wherein the mass ratio of raw material to enzyme is 10:1-30:1, the mass ratio of enzyme to low eutectic solvent is 1:1800-1:200, and the mass ratio of low eutectic solvent to 0.02M PBS buffer is 9:1-1:9.

[0015] The composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent as described in claim 1 is characterized in that the mass ratio of the pectin and carrageenan mixture in the casting liquid is 9:1 to 1:1, and the mixture is dissolved in 20 times the mass of deionized water to obtain its aqueous solution.

[0016] The composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent as described in claim 1 is characterized in that the cross-linking agent added to the casting liquid is calcium lactate, and the mass ratio of calcium lactate to the mixture of pectin and carrageenan is 0.5:1 to 3:1.

[0017] The composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent as described in claim 1 is characterized in that the same low eutectic solvent as that in the hydrolysis system is added to the casting liquid, and the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 1:1 to 4:1.

[0018] The composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent as described in claim 1 is characterized in that the main functional substance added to the casting liquid is animal protein hydrolysate, and the mass ratio of animal protein hydrolysate to the mixture of pectin and carrageenan is 1:1 to 8:1.

[0019] The composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent as described in claim 1 is characterized in that the component that can be added to the casting liquid is heme, and the mass ratio of heme to the mixture of pectin and carrageenan is 1:100 to 9:100.

[0020] The composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent according to claim 1 is characterized in that the dressing is prepared by the following steps: (1) Hydrolysis: A low eutectic solvent and a 0.02M PBS buffer solution are mixed at a mass ratio of 9:1 to 1:9. After the former is completely dissolved, an enzyme is added at a mass ratio of 1:1800 to 1:200, and the mixture is allowed to stand at a hydrolysis temperature of 40 to 60°C for 20 minutes. Subsequently, a defatted animal protein raw material at a mass ratio of 10:1 to 30:1 to the enzyme is added and fully mixed, and then hydrolyzed at 40 to 60°C for 0.5 to 8 hours. After the hydrolysis is completed, the hydrolyzate is inactivated at 100°C for 5 minutes, and then centrifuged at 5000 rpm for 5 minutes. All the supernatant is taken to obtain an animal protein hydrolyzate; (2) Mixing: Pectin and carrageenan are mixed in a mass ratio of 9:1 to 1:1, 20 times the mass of deionized water is added, and the mixture is heated and stirred at 120° C. until it is completely dissolved, followed by adding calcium lactate in a mass ratio of 0.5:1 to 3:1 to the mixture of pectin and carrageenan, and after mixing evenly, a low eutectic solvent for hydrolysis is added in a mass ratio of 1:1 to 4:1 to the mixture of pectin and carrageenan, and after cooling slightly, an animal protein hydrolyzate is added to the system in a mass ratio of 1:1 to 8:1 to the mixture of pectin and carrageenan, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; (3) When it is necessary to add an additive component, add heme in a mass ratio of 1:100 to 9:100 to the mixture of pectin and carrageenan to the uniformly dispersed casting solution, and continue heating and stirring for 3 minutes to completely dissolve it; (4) Concentrating: continuously evaporating the casting solution described in (2) or (3) under vacuum conditions to remove water until the weight stops decreasing; (5) Defoaming: decompression and degassing treatment in a vacuum drying environment; (6) Casting: Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control the formation of a film with a thickness of 0.5 to 1.5 mm; (7) Drying and film removal: After drying at 50°C for 4 hours, the film is peeled off and sealed for later use; (8) Packaging: Cut the finished dressing into certain sizes, sterilize it under ultraviolet light for 60 minutes, and then pack it and store it in a vacuum. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more completely illustrate the technical solution of the specific embodiment of the present invention, the following briefly describes the drawings required in the embodiment. The drawings described are only part of the embodiment of the present invention. For those skilled in the art, it should be possible to obtain other drawings of the embodiment based on these drawings. Among them:

[0022] Figure 1 is the molecular weight distribution of animal protein hydrolysate (the corresponding sample is from Example 8, Figure a is the chromatogram and calibration curve, and Figure b is the molecular weight distribution curve);

[0023] Figure 2 The surface morphology of the composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent in the present invention observed under a scanning electron microscope (the corresponding sample is from Example 8);

[0024] Figure 3 The adhesion of the composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent on different surfaces in the present invention (the corresponding sample is from Example 8);

[0025] Figure 4The stretchability of the composite dressing of the animal protein hydrolysate based on enzyme and low eutectic solvent in the present invention (the corresponding sample is from Example 8);

[0026] Figure 5 The infrared spectrum measurement results of the composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent in the present invention (the corresponding sample is from Example 8);

[0027] Figure 6 The antibacterial property of the composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent in the present invention (Figure a shows the antibacterial effect of Escherichia coli, and Figure b shows the antibacterial effect of Staphylococcus aureus; B1 to B4 are four different composite dressings of pectin / carrageenan, pectin / carrageenan-low eutectic solvent, pectin / carrageenan-low eutectic solvent-heme, pectin / carrageenan-low eutectic solvent-heme-animal protein hydrolysate, and the corresponding samples are from Example 8, and DES, i.e., the low eutectic solvent, is betaine-glycerol);

[0028] Figure 7 The results of the hemoglobin transdermal release experiment of the composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent in the present invention (the corresponding sample is from Example 8). DETAILED DESCRIPTION

[0029] The following is a detailed description of the present invention. Although specific embodiments of the present invention are shown, it should be understood that the present invention can be implemented in various forms and should not be limited by the embodiments set forth herein. On the contrary, these embodiments are provided to enable a more thorough understanding of the present invention and to fully convey the scope of the present invention to those skilled in the art.

[0030] This specification and claims do not use differences in terms as a way to distinguish components, but use differences in the functions of the components as the criteria for distinction. The "include" or "comprising" mentioned in this application is an open-ended term and should be interpreted as "including but not limited to". The embodiments described in the subsequent description are preferred embodiments of the present invention and are based on the general principles of the specification and are not intended to limit the scope of the present invention.

[0031] Example 1

[0032] 0.9 g of low eutectic solvent betaine-glycerol was mixed with 0.1 g of 0.02 M PBS buffer, and after the former was completely dissolved, 0.5 mg of α-chymotrypsin was added, and the mixture was placed at 55° C. for 20 min, and then 5 mg of defatted animal protein raw material was added and fully mixed, and hydrolyzed at 55° C. for 4 h; after the hydrolysis was completed, the hydrolyzate was inactivated at 100° C. for 5 min, and then centrifuged at 5000 rpm for 5 min, and all the supernatant was taken to obtain the animal protein hydrolyzate; the mass ratio of the low eutectic solvent to the PBS buffer was 9:1, the mass ratio of the enzyme to the low eutectic solvent was 1:1800, and the mass ratio of the defatted animal protein raw material to the enzyme was 10:1;

[0033] 0.3 g of pectin and 0.2 g of carrageenan are mixed, 10 g of deionized water is added, and the mixture is heated and stirred at 120° C. until completely dissolved, followed by the addition of 0.2 g of calcium lactate, and after being evenly mixed, 0.5 g of betaine-glycerol is added, and after being slightly cooled, 1.0 g of the above-mentioned animal protein hydrolysate is added to the system, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; the mass ratio of the pectin to the carrageenan is 3:2, the mass ratio of the calcium lactate to the mixture of pectin and carrageenan is 0.4:1, the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 1:1, and the mass ratio of the animal protein hydrolysate to the mixture of pectin and carrageenan is 2:1;

[0034] The casting solution is continuously evaporated to remove water under vacuum conditions until the weight stops decreasing, and a decompression degassing treatment is performed in a vacuum drying environment;

[0035] Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control to form a film with a thickness of 0.5 mm; after drying at 50°C for 4 hours, peel off the film, cut the finished dressing into certain specifications, sterilize it under ultraviolet light for 60 minutes, and then package it and store it in a vacuum.

[0036] Example 2

[0037] 0.7 g of low eutectic solvent betaine-glycerol was mixed with 0.3 g of 0.02 M PBS buffer, and after the former was completely dissolved, 0.5 mg of α-chymotrypsin was added, and the mixture was placed at 55° C. for 20 min, and then 10 mg of defatted animal protein raw material was added and fully mixed, and hydrolyzed at 55° C. for 6 h; after the hydrolysis was completed, the hydrolyzate was inactivated at 100° C. for 5 min, and then centrifuged at 5000 rpm for 5 min, and all the supernatant was taken to obtain the animal protein hydrolyzate; the mass ratio of the low eutectic solvent to the PBS buffer was 7:3, the mass ratio of the enzyme to the low eutectic solvent was 1:1400, and the mass ratio of the defatted animal protein raw material to the enzyme was 20:1;

[0038] 0.4 g of pectin and 0.1 g of carrageenan are mixed, 10 g of deionized water is added, and the mixture is heated and stirred at 120° C. until completely dissolved, followed by the addition of 0.5 g of calcium lactate, and after being evenly mixed, 2.0 g of betaine-glycerol is added, and after being slightly cooled, 4.0 g of the above-mentioned animal protein hydrolysate is added to the system, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; the mass ratio of the pectin to the carrageenan is 4:1, the mass ratio of the calcium lactate to the mixture of pectin and carrageenan is 1:1, the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 4:1, and the mass ratio of the animal protein hydrolysate to the mixture of pectin and carrageenan is 8:1;

[0039] The casting solution is continuously evaporated to remove water under vacuum conditions until the weight stops decreasing, and a decompression degassing treatment is performed in a vacuum drying environment;

[0040] Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control to form a film with a thickness of 0.8 mm; after drying at 50°C for 4 hours, peel off the film, cut the finished dressing into certain specifications, sterilize it under ultraviolet light for 60 minutes, and then package it and store it in a vacuum.

[0041] Example 3

[0042] 0.4 g of low eutectic solvent betaine-glycerol was mixed with 0.6 g of 0.02 M PBS buffer, and after the former was completely dissolved, 0.5 mg of α-chymotrypsin was added, and the mixture was placed at 60° C. for 20 min, and then 7.5 mg of defatted animal protein raw material was added and fully mixed, and hydrolyzed at 60° C. for 3 h; after the hydrolysis was completed, the hydrolyzate was inactivated at 100° C. for 5 min, and then centrifuged at 5000 rpm for 5 min, and all the supernatant was taken to obtain the animal protein hydrolyzate; the mass ratio of the low eutectic solvent to the PBS buffer was 4:6, the mass ratio of the enzyme to the low eutectic solvent was 1:800, and the mass ratio of the defatted animal protein raw material to the enzyme was 15:1;

[0043] 0.45g of pectin and 0.05g of carrageenan are mixed, 10g of deionized water is added, and the mixture is heated and stirred at 120°C until completely dissolved, followed by the addition of 1.0g of calcium lactate, and after being evenly mixed, 1.5g of betaine-glycerol is added, and after being slightly cooled, 2.0g of the above-mentioned animal protein hydrolysate is added to the system, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; the mass ratio of the pectin to the carrageenan is 9:1, the mass ratio of the calcium lactate to the mixture of pectin and carrageenan is 2:1, the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 3:1, and the mass ratio of the animal protein hydrolysate to the mixture of pectin and carrageenan is 4:1;

[0044] The casting solution is continuously evaporated to remove water under vacuum conditions until the weight stops decreasing, and a decompression degassing treatment is performed in a vacuum drying environment;

[0045] Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control to form a film with a thickness of 0.6 mm; after drying at 50°C for 4 hours, peel off the film, cut the finished dressing into certain specifications, sterilize it under ultraviolet light for 60 minutes, and then package it and store it in a vacuum.

[0046] Example 4

[0047] 0.1 g of a low eutectic solvent betaine-glycerol was mixed with 0.9 g of a 0.02 M PBS buffer solution, and after the former was completely dissolved, 0.5 mg of α-chymotrypsin was added, and the mixture was placed at 40° C. for 20 min, and then 10 mg of a defatted animal protein raw material was added and mixed thoroughly, and hydrolyzed at 40° C. for 8 h; after the hydrolysis was completed, the hydrolyzate was inactivated at 100° C. for 5 min, and then centrifuged at 5000 rpm for 5 min, and all the supernatant was taken to obtain an animal protein hydrolyzate; the mass ratio of the low eutectic solvent to the PBS buffer solution was 1:9, the mass ratio of the enzyme to the low eutectic solvent was 1:200, and the mass ratio of the defatted animal protein raw material to the enzyme was 20:1;

[0048] 0.35g of pectin and 0.15g of carrageenan are mixed, 10g of deionized water is added, and the mixture is heated and stirred at 120°C until completely dissolved, followed by the addition of 1.5g of calcium lactate, and after being evenly mixed, 1.0g of betaine-glycerol is added, and after being slightly cooled, 1.5g of the above-mentioned animal protein hydrolysate is added to the system, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; the mass ratio of the pectin to the carrageenan is 7:3, the mass ratio of the calcium lactate to the mixture of pectin and carrageenan is 3:1, the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 2:1, and the mass ratio of the animal protein hydrolysate to the mixture of pectin and carrageenan is 3:1;

[0049] The casting solution is continuously evaporated to remove water under vacuum conditions until the weight stops decreasing, and a decompression degassing treatment is performed in a vacuum drying environment;

[0050] Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control to form a film with a thickness of 1.1 mm; after drying at 50°C for 4 hours, peel off the film, cut the finished dressing into certain specifications, sterilize it under ultraviolet light for 60 minutes, and then package it and store it in a vacuum.

[0051] Example 5

[0052] 0.1 g of a low eutectic solvent betaine-glycerol was mixed with 0.9 g of a 0.02 M PBS buffer solution, and after the former was completely dissolved, 0.5 mg of α-chymotrypsin was added, and the mixture was placed at 40° C. for 20 min, and then 5 mg of defatted animal protein raw material was added and mixed thoroughly, and hydrolyzed at 40° C. for 8 h; after the hydrolysis was completed, the hydrolyzate was inactivated at 100° C. for 5 min, and then centrifuged at 5000 rpm for 5 min, and all the supernatant was taken to obtain an animal protein hydrolyzate; the mass ratio of the low eutectic solvent to the PBS buffer solution was 1:9, the mass ratio of the enzyme to the low eutectic solvent was 1:200, and the mass ratio of the defatted animal protein raw material to the enzyme was 10:1;

[0053] 0.35g of pectin and 0.15g of carrageenan are mixed, 10g of deionized water is added, and the mixture is heated and stirred at 120°C until completely dissolved, followed by the addition of 1.5g of calcium lactate, and after being evenly mixed, 0.5g of betaine-glycerol is added, and after being slightly cooled, 0.5g of the above-mentioned animal protein hydrolysate is added to the system, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; the mass ratio of the pectin to the carrageenan is 7:3, the mass ratio of the calcium lactate to the mixture of pectin and carrageenan is 3:1, the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 1:1, and the mass ratio of the animal protein hydrolysate to the mixture of pectin and carrageenan is 1:1;

[0054] The casting solution is continuously evaporated to remove water under vacuum conditions until the weight stops decreasing, and a decompression degassing treatment is performed in a vacuum drying environment;

[0055] Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control to form a film with a thickness of 1.3 mm; after drying at 50°C for 4 hours, peel off the film, cut the finished dressing into certain specifications, sterilize it under ultraviolet light for 60 minutes, and then package it and store it in a vacuum.

[0056] Example 6

[0057] 0.5 g of a low eutectic solvent betaine-glycerol was mixed with 0.5 g of a 0.02 M PBS buffer solution, and after the former was completely dissolved, 0.5 mg of α-chymotrypsin was added, and the mixture was placed at 55° C. for 20 min, and then 15 mg of a defatted animal protein raw material was added and mixed thoroughly, and hydrolyzed at 55° C. for 0.6 h; after the hydrolysis was completed, the hydrolyzate was inactivated at 100° C. for 5 min, and then centrifuged at 5000 rpm for 5 min, and all the supernatant was taken to obtain an animal protein hydrolyzate; the mass ratio of the low eutectic solvent to the PBS buffer solution was 1:1, the mass ratio of the enzyme to the low eutectic solvent was 1:1000, and the mass ratio of the defatted animal protein raw material to the enzyme was 30:1;

[0058] 0.25 g of pectin and 0.25 g of carrageenan are mixed, 10 g of deionized water is added, and the mixture is heated and stirred at 120° C. until completely dissolved, followed by the addition of 0.5 g of calcium lactate, and after being evenly mixed, 0.5 g of betaine-glycerol is added, and after being slightly cooled, 2.0 g of the above-mentioned animal protein hydrolysate is added to the system, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; the mass ratio of the pectin to the carrageenan is 1:1, the mass ratio of the calcium lactate to the mixture of pectin and carrageenan is 1:1, the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 1:1, and the mass ratio of the animal protein hydrolysate to the mixture of pectin and carrageenan is 4:1;

[0059] When it is necessary to add additive components, 5 mg of heme is added to the uniformly dispersed casting solution in this step, and heating is continued for 3 minutes to completely dissolve it to obtain a casting solution containing heme, the mass ratio of the former to the mixture of pectin and carrageenan is 1:100.

[0060] The above-mentioned additive component heme is obtained from the congested blood tissue discarded from the minced meat food industry. The specific operation method is as follows:

[0061] An equal volume of deionized water was added to the congested tissue homogenate, and the homogenate was crushed by ultrasound at a power of 200 W for 10 min, followed by centrifugation at 5000 rpm for 10 min, and all the supernatant was collected to obtain the hemoglobin solution;

[0062] Add 5 volumes of acetone to the hemoglobin solution, adjust the pH value to 2.2 with 1 mol / L dilute HCl, and collect the filtrate after suction filtration; add 5% tannic acid to the filtrate, let it stand for 12 hours; filter and collect all the precipitates, and wash them twice with deionized water, 50% acetic acid, 95% ethanol, and ether respectively, and dry the obtained product in the dark. The red-purple solid finally obtained is hemoglobin (chloride);

[0063] The heme-containing casting solution is continuously evaporated to remove water under vacuum conditions until the weight stops decreasing, and a decompression degassing treatment is performed in a vacuum drying environment;

[0064] Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control to form a film with a thickness of 0.7 mm; after drying at 50°C for 4 hours, peel off the film, cut the finished dressing into certain specifications, sterilize it under ultraviolet light for 60 minutes, and then package it and store it in a vacuum.

[0065] Example 7

[0066] 0.4 g of low eutectic solvent betaine-glycerol was mixed with 0.6 g of 0.02 M PBS buffer, and after the former was completely dissolved, 0.5 mg of α-chymotrypsin was added, and the mixture was placed at 55° C. for 20 min, and then 15 mg of defatted animal protein raw material was added and fully mixed, and hydrolyzed at 55° C. for 0.8 h; after the hydrolysis was completed, the hydrolyzate was inactivated at 100° C. for 5 min, and then centrifuged at 5000 rpm for 5 min, and all the supernatant was taken to obtain the animal protein hydrolyzate; the mass ratio of the low eutectic solvent to the PBS buffer was 4:6, the mass ratio of the enzyme to the low eutectic solvent was 1:800, and the mass ratio of the defatted animal protein raw material to the enzyme was 30:1;

[0067] 0.4 g of pectin and 0.1 g of carrageenan are mixed, 10 g of deionized water is added, and the mixture is heated and stirred at 120° C. until completely dissolved, followed by the addition of 1.0 g of calcium lactate, and after being evenly mixed, 1.5 g of betaine-glycerol is added, and after being slightly cooled, 4.0 g of the above-mentioned animal protein hydrolysate is added to the system, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; the mass ratio of the pectin to the carrageenan is 4:1, the mass ratio of the calcium lactate to the mixture of pectin and carrageenan is 2:1, the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 3:1, and the mass ratio of the animal protein hydrolysate to the mixture of pectin and carrageenan is 8:1;

[0068] When it is necessary to add the additive component, 30 mg of heme is added to the uniformly dispersed casting solution in this step, and the mixture is heated for 3 min to completely dissolve the heme, thereby obtaining a casting solution containing heme, the mass ratio of which to the mixture of pectin and carrageenan is 6:100;

[0069] The heme-containing casting solution is continuously evaporated to remove water under vacuum conditions until the weight stops decreasing, and a decompression degassing treatment is performed in a vacuum drying environment;

[0070] Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control to form a film with a thickness of 1.3 mm; after drying at 50°C for 4 hours, peel off the film, cut the finished dressing into certain specifications, sterilize it under ultraviolet light for 60 minutes, and then package it and store it in a vacuum.

[0071] Example 8

[0072] 0.4 g of low eutectic solvent betaine-glycerol was mixed with 0.6 g of 0.02 M PBS buffer, and after the former was completely dissolved, 0.5 mg of α-chymotrypsin was added, and the mixture was placed at 55° C. for 20 min, and then 10 mg of defatted animal protein raw material was added and fully mixed, and hydrolyzed at 55° C. for 3 h; after the hydrolysis was completed, the hydrolyzate was inactivated at 100° C. for 5 min, and then centrifuged at 5000 rpm for 5 min, and all the supernatant was taken to obtain the animal protein hydrolyzate; the mass ratio of the low eutectic solvent to the PBS buffer was 4:6, the mass ratio of the enzyme to the low eutectic solvent was 1:800, and the mass ratio of the defatted animal protein raw material to the enzyme was 20:1;

[0073] 0.4 g of pectin and 0.1 g of carrageenan are mixed, 10 g of deionized water is added, and the mixture is heated and stirred at 120° C. until completely dissolved, followed by the addition of 1.0 g of calcium lactate, and after being evenly mixed, 2.0 g of betaine-glycerol is added, and after being slightly cooled, 2.0 g of the above-mentioned animal protein hydrolysate is added to the system, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; the mass ratio of the pectin to the carrageenan is 4:1, the mass ratio of the calcium lactate to the mixture of pectin and carrageenan is 2:1, the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 4:1, and the mass ratio of the animal protein hydrolysate to the mixture of pectin and carrageenan is 4:1;

[0074] When it is necessary to add the additive component, 45 mg of heme is added to the uniformly dispersed casting solution in this step, and the mixture is heated for 3 min to completely dissolve the heme, thereby obtaining a casting solution containing heme, the mass ratio of which to the mixture of pectin and carrageenan is 9:100;

[0075] The heme-containing casting solution is continuously evaporated to remove water under vacuum conditions until the weight stops decreasing, and a decompression degassing treatment is performed in a vacuum drying environment;

[0076] Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control to form a film with a thickness of 1.4 mm; after drying at 50°C for 4 hours, peel off the film, cut the finished dressing into certain specifications, sterilize it under ultraviolet light for 60 minutes, and then package it and store it in a vacuum.

[0077] Example 9

[0078] 0.2 g of low eutectic solvent betaine-glycerol was mixed with 0.8 g of 0.02 M PBS buffer, and after the former was completely dissolved, 0.5 mg of α-chymotrypsin was added, and the mixture was placed at 50° C. for 20 min, and then 10 mg of defatted animal protein raw material was added and fully mixed, and hydrolyzed at 50° C. for 1 h; after the hydrolysis was completed, the hydrolyzate was inactivated at 100° C. for 5 min, and then centrifuged at 5000 rpm for 5 min, and all the supernatant was taken to obtain the animal protein hydrolyzate; the mass ratio of the low eutectic solvent to the PBS buffer was 2:8, the mass ratio of the enzyme to the low eutectic solvent was 1:400, and the mass ratio of the defatted animal protein raw material to the enzyme was 20:1;

[0079] 0.3g of pectin and 0.2g of carrageenan are mixed, 10g of deionized water is added, and the mixture is heated and stirred at 120°C until completely dissolved, followed by the addition of 0.25g of calcium lactate, and after being evenly mixed, 0.8g of betaine-glycerol is added, and after being slightly cooled, 1.0g of the above-mentioned animal protein hydrolysate is added to the system, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; the mass ratio of the pectin to the carrageenan is 3:2, the mass ratio of the calcium lactate to the mixture of pectin and carrageenan is 0.5:1, the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 1.6:1, and the mass ratio of the animal protein hydrolysate to the mixture of pectin and carrageenan is 2:1;

[0080] When it is necessary to add the additive component, 15 mg of heme is added to the uniformly dispersed casting solution in this step, and the mixture is heated for 3 min to completely dissolve the heme, thereby obtaining a casting solution containing heme, the mass ratio of which to the mixture of pectin and carrageenan is 3:100;

[0081] The heme-containing casting solution is continuously evaporated to remove water under vacuum conditions until the weight stops decreasing, and a decompression degassing treatment is performed in a vacuum drying environment;

[0082] Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control to form a film with a thickness of 1.5 mm; after drying at 50°C for 4 hours, peel off the film, cut the finished dressing into certain specifications, sterilize it under ultraviolet light for 60 minutes, and then package it and store it in a vacuum.

[0083] For the composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent obtained in Examples 1 to 9, the overall properties and adhesion of the product prepared with defatted pork powder as raw material were compared. The latter was measured according to the adhesion test method in the general rules of Part IV of the 2020 edition of the Chinese Pharmacopoeia. The results are shown in Table 1:

[0084] Table 1 Overall properties and adhesion of finished products obtained under different experimental conditions Serial number Overall characteristics Adhesion force (g) Example 1 Better uniformity, better softness, better film-forming properties 150.1±10.3 Example 2 Better uniformity, better softness, better film-forming properties 635.9±30.0 Example 3 Better uniformity, better softness, better film-forming properties 338.2±21.1 Example 4 Average uniformity, average softness, good film-forming properties 199.8±11.1 Example 5 Poor uniformity, good softness, average film-forming property 113.8±9.7 Example 6 Average uniformity, good softness, average film-forming properties 151.2±16.2 Example 7 Average uniformity, good softness, good film-forming properties 287.6±22.3 Example 8 Good uniformity, average softness, good film-forming properties 639.9±19.9 Example 9 Good uniformity, average softness, good film-forming properties 368.7±14.3

[0085] The molecular weight distribution of the animal protein hydrolysate prepared from defatted pork powder in Example 8 was tested; specifically, a Rid-20A high performance gel chromatograph (Shimadzu, Kyoto, Japan) was used for the determination, the chromatographic column used was Shim-pack GPC-8025, and the mobile phase was water. The results showed that the average molecular weight (Mw) of the hydrolysate was about 621 Da, and the molecular weight distribution range was 87 to 25931 Da.

[0086] The results of the molecular weight distribution test are attached. Figure 1 It can be seen that its molecular weight is mainly distributed around 352Da. Since the average molecular weight of amino acids is about 120Da, this result shows that the hydrolysis system still contains short-chain peptides, and most of them are in the range of 180 to 500Da, which are small molecule peptides that are easier for the human body to absorb and utilize.

[0087] The surface morphology of the composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent prepared in Example 8 was observed using a scanning electron microscope, as shown in the attached figure. Figure 2 As shown; the results show that the film is smooth and flat as a whole, without wrinkles, grooves, bubbles or cracks, and has good homogeneity.

[0088] The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent prepared in Example 8 was tested for its conformability. Figure 3 As shown; the results show that the dressing has good adhesion on plastics, paper, polytetrafluoroethylene (PTFE), metal sheets, skin and glass surfaces with different smoothness and curvature.

[0089] The tensile properties of the composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent prepared in Example 8 were tested. Figure 4 As shown; the results show that the dressing can be stretched to 1.8 times its initial length and has resilience.

[0090] The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent prepared in Example 8 was analyzed by infrared spectroscopy, and the attenuated total reflection (ATR) mode was used for the test. The results are shown in the attached figure. Figure 5 As shown;

[0091] The following is a brief analysis of the above infrared spectrum measurement results: 3000~3500cm -1 The stretching vibration absorption peaks of OH and NH bonds in the dressing components appeared in the wave number range of 2873 and 2864 cm -1This corresponds to the CH stretching vibration in the polysaccharide backbone chain. In addition, there is a typical amide I peak at 1637 cm -1 These all suggest the existence of related components.

[0092] The antibacterial test was carried out on the composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent prepared in Example 8. The experimental method was in accordance with the national standard GB / T 37206-2018. The results are shown in the attached Figure 6 As shown;

[0093] The following is a brief analysis of the above antibacterial experimental results: From the diameter of the antibacterial circle, it can be seen that the composite dressing has a good antibacterial effect on two common pathogens. Among them, betaine-propylene glycol DES has the strongest antibacterial ability against both bacteria, which is better than the prepared composite dressing film, and can reach a maximum of about 19.0 mm. The pure basement membrane (B1) has almost no strong antibacterial ability. When the above DES is added (B2), its antibacterial ability has increased significantly. When heme is continued to be added to the basement membrane (B3), its antibacterial circle also increases. When protein hydrolyzate is added (B4), the antibacterial circle of the composite dressing film does not change significantly, indicating that it is not the main active ingredient that exerts an antibacterial effect.

[0094] The hemoglobin transdermal release behavior of the composite dressing of animal protein hydrolyzate based on enzyme and low eutectic solvent prepared in Example 8 was investigated. Here, 1 mL of sample was taken each time in the range of 0.5 to 24 h by Franz diffusion cell method. The absorbance of the obtained sample was measured at 384 nm by UV-visible spectrometer with normal saline as blank group. Calculate the cumulative transmittance per unit area, where Q n is the cumulative permeation amount of the nth sample, μg / mL; C n , C i is the concentration of the nth sample, μg / mL; V i is the volume of the sample, mL; V is the amount of receiving liquid in the receiving pool, mL; S is the effective diffusion area, cm 2 ; The results are as follows Figure 7 As shown;

[0095] The following is a brief analysis of the above transdermal release experimental results: the cumulative permeation amount of hemoglobin increases with the increase of permeation time, and it can be found that the release rate of hemoglobin is faster in the initial stage, and the release rate shows a gradually decreasing trend in 12 to 24 hours. The total release rate of 24 hours is 70.75%.

Claims

1. A composite dressing of animal protein hydrolysate based on enzyme and low eutectic solvent, characterized in that: The animal protein raw materials used come from defatted waste residues in the meat processing process of the food industry, including pork, beef, chicken or a mixture thereof, wherein pork waste is mainly used.

2. The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent according to claim 1, characterized in that: The enzymes used include trypsin, α-chymotrypsin, papain or flavorin.

3. The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent according to claim 1, characterized in that: The deep eutectic solvents used include choline chloride-urea (1:2), choline chloride-ethylene glycol (1:2), choline chloride-glycerol (1:2) or betaine-glycerol (1:2).

4. The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent according to claim 1, characterized in that: The hydrolysis system consists of animal protein raw materials, enzymes, low eutectic solvents and 0.02M PBS buffer, wherein the mass ratio of the raw materials to the enzyme is 10:1-30:1, the mass ratio of the enzyme to the low eutectic solvent is 1:1800-1:200, and the mass ratio of the low eutectic solvent to the 0.02M PBS buffer is 9:1-1:

9.

5. The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent according to claim 1, characterized in that: The mass ratio of the pectin and carrageenan mixture in the casting solution is 9:1-1:1, and the mixture is dissolved in 20 times the mass of deionized water to obtain an aqueous solution.

6. The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent according to claim 1, characterized in that: The cross-linking agent added to the casting solution is calcium lactate, and the mass ratio of calcium lactate to the mixture of pectin and carrageenan is 0.5:1 to 3:

1.

7. The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent according to claim 1, characterized in that: The same low eutectic solvent as that in the hydrolysis system is added to the casting solution, and the mass ratio of the low eutectic solvent to the mixture of pectin and carrageenan is 1:1 to 4:

1.

8. The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent according to claim 1, characterized in that: The main active ingredient added to the casting solution is animal protein hydrolysate, and the mass ratio of animal protein hydrolysate to the mixture of pectin and carrageenan is 1:1 to 8:

1.

9. The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent according to claim 1, characterized in that: The component that can be added to the casting solution is heme, and the mass ratio of heme to the mixture of pectin and carrageenan is 1:100 to 9:

100.

10. The composite dressing of animal protein hydrolysate based on enzyme and deep eutectic solvent according to claim 1, characterized in that: The dressing is prepared by the following steps: (1) Hydrolysis: A low eutectic solvent and a 0.02M PBS buffer solution are mixed at a mass ratio of 9:1 to 1:

9. After the former is completely dissolved, an enzyme is added at a mass ratio of 1:1800 to 1:200, and the mixture is allowed to stand at a hydrolysis temperature of 40 to 60°C for 20 minutes. Subsequently, a defatted animal protein raw material at a mass ratio of 10:1 to 30:1 to the enzyme is added and fully mixed, and then hydrolyzed at 40 to 60°C for 0.5 to 8 hours. After the hydrolysis is completed, the hydrolyzate is inactivated at 100°C for 5 minutes, and then centrifuged at 5000 rpm for 5 minutes. All the supernatant is taken to obtain an animal protein hydrolyzate; (2) Mixing: Pectin and carrageenan are mixed in a mass ratio of 9:1 to 1:1, 20 times the mass of deionized water is added, and the mixture is heated and stirred at 120° C. until it is completely dissolved, followed by adding calcium lactate in a mass ratio of 0.5:1 to 3:1 to the mixture of pectin and carrageenan, and after mixing evenly, a low eutectic solvent for hydrolysis is added in a mass ratio of 1:1 to 4:1 to the mixture of pectin and carrageenan, and after cooling slightly, an animal protein hydrolyzate is added to the system in a mass ratio of 1:1 to 8:1 to the mixture of pectin and carrageenan, and the mixture is fully stirred to be evenly dispersed to obtain a casting solution; (3) When it is necessary to add an additive component, add heme in a mass ratio of 1:100 to 9:100 to the mixture of pectin and carrageenan to the uniformly dispersed casting solution, and continue heating and stirring for 3 minutes to completely dissolve it; (4) Concentrating: continuously evaporating the casting solution described in (2) or (3) under vacuum conditions to remove water until the weight stops decreasing; (5) Defoaming: decompression and degassing treatment in a vacuum drying environment; (6) Casting: Pour the casting liquid onto a smooth and clean mold surface, wait for it to flow naturally and control the formation of a film with a thickness of 0.5 to 1.5 mm; (7) Drying and film removal: After drying at 50°C for 4 hours, the film is peeled off and sealed for later use; (8) Packaging: Cut the finished dressing into certain sizes, sterilize it under ultraviolet light for 60 minutes, and then pack it and store it in a vacuum.